• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moleculin Biotech CS (NQ: MBRX )

    4.770 +0.130 (+2.80%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,875
    Open 4.730
    Bid (Size) 4.770 (2)
    Ask (Size) 4.880 (4)
    Prev. Close 4.640
    Today's Range 4.729 - 4.870
    52wk Range 0.3377 - 6.240
    Shares Outstanding 2,227,516
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
    MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    +416.18%
    +416.18%
    1 Month
    +9.66%
    +9.66%
    3 Month
    +783.66%
    +783.66%
    6 Month
    +750.27%
    +750.27%
    1 Year
    +708.47%
    +708.47%

    More News

    Read More
    Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
    Via InvestorPlace
    A Preview Of Moleculin Biotech's Earnings
    Via Benzinga
    Moleculin Biotech's Earnings: A Preview
    Via Benzinga
    Earnings Scheduled For March 22, 2024
    Via Benzinga
    Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Earnings Scheduled For November 13, 2023
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.